YOQNEAM, ISRAEL, May 29 (MARKET WIRE) --
Given Imaging (NASDAQ: GIVN) today announced that the company will host a
conference call on June 3, 2009 to review PillCam SB video capsule and
Bravo pH Monitoring System abstracts presented at Digestive Disease Week
2009 taking place May 30 - June 4 in Chicago. Deborah Mutter, Given
Imaging's Corporate Manager, Clinical Marketing, will be joined by Dr.
Ian M. Gralnek, Head, GI Outcomes Unit and Senior Physician Department of
Gastroenterology Rambam Health Care Campus in Haifa, Israel, and Dr. John
Pandolfino, Professor of Medicine, Feinberg School of Medicine,
Northwestern University. The call will take place at 11:00am CT, 12:00pm
ET.
To participate in this teleconference, please dial 888-224-1065 fifteen
minutes before the conference is scheduled to begin. Callers outside of
the U.S. should dial 913-312-1438. The call will also be webcast live at
www.givenimaging.com. A replay of the call will be available for two weeks
on the company's website, or until May 21 by dialing 888-203-1112. Callers
outside of the U.S. should dial 719-457-0820. The replay participant code
is 1724821.
About Given Imaging Ltd.
Since 2001 Given Imaging has advanced gastrointestinal diagnosis by
developing innovative, patient-friendly tools based on its PillCam(R)
Platform. PillCam capsule endoscopy provides physicians with natural
images of the small intestine via PillCam SB, the esophagus through
PillCam ESO and the colon with PillCam COLON [not cleared for use in the
USA]. The PillCam capsules are miniature video cameras that patients
ingest. Given Imaging's other capsule products include Agile(TM) patency
capsule, to verify intestinal patency, and Bravo(R), the only wireless,
catheter-free, 48-hour pH test commercially available for pH testing to
assess gastroesophageal reflux disease (GERD). Given Imaging's products
use cutting-edge wireless technology and advanced software to enable
gastroenterologists to better diagnose and more accurately treat patients.
All Given Imaging products allow patients to maintain normal activities.
Given Imaging's headquarters, manufacturing and R&D facilities are located
in Yoqneam, Israel, with operating subsidiaries in the United States,
Germany, France, Japan, Australia and Singapore. For more information,
please visit http://www.givenimaging.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning
of the "safe harbor" provisions of the U.S. Private Securities Litigation
Reform Act of 1995. These forward-looking statements include, but are not
limited to, projections about our business and our future revenues,
expenses and profitability. Forward-looking statements may be, but are not
necessarily, identified by the use of forward-looking terminology such as
"may," "anticipates," "estimates," "expects," "intends," "plans,"
"believes," and words and terms of similar substance. Forward-looking
statements involve known and unknown risks, uncertainties and other
factors which may cause the actual events, results, performance,
circumstances or achievements of the Company to be materially different
from any future events, results, performance, circumstances or
achievements expressed or implied by such forward-looking statements.
Factors that could cause actual events, results, performance,
circumstances or achievements to differ from such forward-looking
statements include, but are not limited to, the following: (1) our
ability to develop and bring to market new products, (2) our ability to
receive regulatory clearance or approval to market our products or
changes in regulatory environment, (3) our success in implementing our
sales, marketing and manufacturing plans, (4) protection and validity of
patents and other intellectual property rights, (5) the impact of
currency exchange rates, (6) the effect of competition by other
companies, (7) the outcome of significant litigation, (8) our ability to
obtain reimbursement for our product from government and commercial
payors, (9) quarterly variations in operating results, (10) the
possibility of armed conflict or civil or military unrest in Israel, (11)
the impact of global economic conditions, and (12) other risks and
factors disclosed in our filings with the U.S. Securities and Exchange
Commission, including, but not limited to, risks and factors identified
under such headings as "Risk Factors," "Cautionary Language Regarding
Forward-Looking Statements" and "Operating Results and Financial Review
and Prospects" in the Company's Annual Report on Form 20-F for the year
ended December 31, 2008. You are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date of this
press release. Except for the Company's ongoing obligations to disclose
material information under the applicable securities laws, it undertakes
no obligation to release publicly any revisions to any forward-looking
statements, to report events or to report the occurrence of unanticipated
events.
For further information contact:
Fern Lazar/David Carey
Lazar Partners Ltd.
1-866-GIVEN-IR
Email Contact/
Email Contact
Copyright 2009, Market Wire, All rights reserved.
-0-
